ConforMIS Company Profile (NASDAQ:CFMS)


ConforMIS logoConforMIS, Inc. is a medical technology company. The Company uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants, which are individually sized and shaped, to fit each patient's anatomy. The Company's iFit technology platform is applicable to various joints. It offers a line of customized knee implants designed to restore the natural shape of a patient's knee. It offers iTotal CR, which is a total knee replacement implant. Its iFit technology platform consists of three elements, including iFit Design, its algorithms and computer software that is used to design customized implants and associated single-use patient-specific instrumentation referred to as iJigs, based on computed tomography scans of the patient and to prepare a surgical plan customized for the patient (iView); iFit Printing, which is a three-dimensional printing technology used to manufacture iJigs, and iFit Just-in-Time manufacturing and delivery capabilities.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Devices & Implants
  • Sub-Industry: N/A
  • Symbol: NASDAQ:CFMS
  • CUSIP: N/A
  • Web:
  • Market Cap: $175.31 million
  • Outstanding Shares: 44,836,000
Average Prices:
  • 50 Day Moving Avg: $4.32
  • 200 Day Moving Avg: $5.11
  • 52 Week Range: $3.22 - $10.93
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.45
  • P/E Growth: 0.22
Sales & Book Value:
  • Annual Revenue: $79.26 million
  • Price / Sales: 2.05
  • Book Value: $1.52 per share
  • Price / Book: 2.38
  • EBIDTA: ($54,780,000.00)
  • Net Margins: -72.87%
  • Return on Equity: -66.61%
  • Return on Assets: -49.87%
  • Debt-to-Equity Ratio: 0.43%
  • Current Ratio: 6.98%
  • Quick Ratio: 6.11%
  • Average Volume: 375,728 shs.
  • Beta: 2.25
  • Short Ratio: 9.83
Frequently Asked Questions for ConforMIS (NASDAQ:CFMS)

What is ConforMIS's stock symbol?

ConforMIS trades on the NASDAQ under the ticker symbol "CFMS."

How were ConforMIS's earnings last quarter?

ConforMIS, Inc. (NASDAQ:CFMS) released its earnings results on Thursday, August, 3rd. The company reported ($0.28) earnings per share for the quarter, beating analysts' consensus estimates of ($0.36) by $0.08. The company earned $18.50 million during the quarter, compared to analyst estimates of $19.34 million. ConforMIS had a negative return on equity of 66.61% and a negative net margin of 72.87%. ConforMIS's revenue for the quarter was down 4.1% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.34) EPS. View ConforMIS's Earnings History.

Where is ConforMIS's stock going? Where will ConforMIS's stock price be in 2017?

7 brokers have issued 1-year price targets for ConforMIS's shares. Their forecasts range from $5.00 to $14.00. On average, they expect ConforMIS's share price to reach $8.25 in the next year. View Analyst Ratings for ConforMIS.

Who are some of ConforMIS's key competitors?

Who are ConforMIS's key executives?

ConforMIS's management team includes the folowing people:

  • Kenneth Fallon III, Independent Chairman of the Board
  • Mark A. Augusti, President, Chief Executive Officer, Director
  • Paul S. Weiner, Chief Financial Officer
  • Dan Krupp, Senior Vice President - U.S. Sales
  • Daniel Steines M.D., Chief Technology Officer
  • David Cerveny, Chief Legal Officer and General Counsel
  • Philipp Lang M.D., Director
  • Bradley R. Langdale, Independent Director
  • Colm C. Lanigan, Independent Director
  • Richard J. Meelia, Independent Director

When did ConforMIS IPO?

(CFMS) raised $135 million in an initial public offering on Wednesday, July 1st 2015. The company issued 9,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Deutsche Bank Securities acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

Who owns ConforMIS stock?

ConforMIS's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (3.61%), C Partners Holding Gmbh (3.38%), State Street Corp (1.33%), Northern Trust Corp (1.04%), Platinum Investment Management Ltd. (0.75%) and Columbus Circle Investors (0.51%). Company insiders that own ConforMIS stock include Bradley Langdale, Daniel Steines, David Cerveny, Kenneth P Fallon III, Paul S Weiner, Philipp Lang and Robert Law III. View Institutional Ownership Trends for ConforMIS.

Who sold ConforMIS stock? Who is selling ConforMIS stock?

ConforMIS's stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Frontier Capital Management Co. LLC, Marathon Capital Management, Creative Planning, Goldman Sachs Group Inc., California State Teachers Retirement System and New York State Common Retirement Fund. Company insiders that have sold ConforMIS stock in the last year include Bradley Langdale, Daniel Steines, David Cerveny, Kenneth P Fallon III, Paul S Weiner and Philipp Lang. View Insider Buying and Selling for ConforMIS.

Who bought ConforMIS stock? Who is buying ConforMIS stock?

ConforMIS's stock was purchased by a variety of institutional investors in the last quarter, including ARK Investment Management LLC, Spark Investment Management LLC, PDT Partners LLC, Columbus Circle Investors, Platinum Investment Management Ltd., Northern Trust Corp, Bank of New York Mellon Corp and Trent Capital Management Inc. NC. View Insider Buying and Selling for ConforMIS.

How do I buy ConforMIS stock?

Shares of ConforMIS can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ConforMIS's stock price today?

One share of ConforMIS stock can currently be purchased for approximately $3.62.

MarketBeat Community Rating for ConforMIS (NASDAQ CFMS)
Community Ranking:  2.7 out of 5 ( )
Outperform Votes:  135 (Vote Outperform)
Underperform Votes:  119 (Vote Underperform)
Total Votes:  254
MarketBeat's community ratings are surveys of what our community members think about ConforMIS and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for ConforMIS (NASDAQ:CFMS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 4 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.43)
Consensus Price Target: $8.25 (127.90% upside)

Analysts' Ratings History for ConforMIS (NASDAQ:CFMS)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/4/2017Canaccord GenuityLower Price TargetHold$8.00 -> $6.00LowView Rating Details
8/4/2017Oppenheimer Holdings, Inc.Set Price TargetBuy$6.00HighView Rating Details
8/4/2017Deutsche Bank AGReiterated RatingBuy -> Hold$6.00 -> $5.00HighView Rating Details
7/16/2017BTIG ResearchReiterated RatingHoldLowView Rating Details
5/16/2017B. RileyReiterated RatingBuy$7.50LowView Rating Details
11/4/2016J P Morgan Chase & CoReiterated RatingHold$11.00N/AView Rating Details
9/19/2016SunTrust Banks, Inc.Initiated CoverageBuy$14.00N/AView Rating Details
5/13/2016Wells Fargo & CompanyDowngradeOutperform -> Market PerformN/AView Rating Details
12/1/2015Sterne Agee CRTInitiated CoverageBuy$26.00N/AView Rating Details
(Data available from 8/16/2015 forward)


Earnings History for ConforMIS (NASDAQ:CFMS)
Earnings by Quarter for ConforMIS (NASDAQ:CFMS)
Earnings History by Quarter for ConforMIS (NASDAQ CFMS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/3/2017Q2 2017($0.36)($0.28)$19.34 million$18.50 millionViewListenView Earnings Details
5/10/2017Q1 2017($0.36)($0.40)$18.48 million$20.50 millionViewN/AView Earnings Details
2/15/2017Q416($0.30)($0.37)$21.37 million$21.70 millionViewListenView Earnings Details
11/3/2016Q316($0.36)($0.31)$18.27 million$18.60 millionViewListenView Earnings Details
8/8/2016Q216($0.35)($0.34)$18.02 million$19.30 millionViewListenView Earnings Details
5/12/2016Q116($0.38)($0.37)$19.23 million$20.30 millionViewListenView Earnings Details
2/11/2016Q415($0.41)($0.37)$17.23 million$19.10 millionViewListenView Earnings Details
11/2/2015Q3($0.38)($0.45)$13.51 million$13.90 millionViewN/AView Earnings Details
8/11/2015Q215($1.31)($2.51)$11.20 million$19.20 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for ConforMIS (NASDAQ:CFMS)
2017 EPS Consensus Estimate: ($1.41)
2018 EPS Consensus Estimate: ($1.21)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173($0.38)($0.36)($0.37)
Q2 20173($0.39)($0.35)($0.37)
Q3 20173($0.37)($0.29)($0.34)
Q4 20173($0.35)($0.31)($0.33)
Q1 20182($0.34)($0.29)($0.32)
Q2 20182($0.34)($0.28)($0.31)
Q3 20182($0.34)($0.23)($0.29)
Q4 20182($0.34)($0.26)($0.30)
(Data provided by Zacks Investment Research)


Dividend History for ConforMIS (NASDAQ:CFMS)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for ConforMIS (NASDAQ:CFMS)
Insider Ownership Percentage: 9.55%
Institutional Ownership Percentage: 38.58%
Insider Trades by Quarter for ConforMIS (NASDAQ:CFMS)
Institutional Ownership by Quarter for ConforMIS (NASDAQ:CFMS)
Insider Trades by Quarter for ConforMIS (NASDAQ:CFMS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/20/2017Bradley LangdaleDirectorSell6,722$4.30$28,904.60View SEC Filing  
4/26/2017Daniel SteinesInsiderSell5,000$5.54$27,700.00View SEC Filing  
4/5/2017Daniel SteinesInsiderSell5,000$5.00$25,000.00View SEC Filing  
2/15/2017Philipp LangDirectorSell137,968$8.60$1,186,524.80View SEC Filing  
2/3/2017David CervenyInsiderSell3,569$8.59$30,657.71View SEC Filing  
2/3/2017Paul S WeinerCFOSell2,676$8.42$22,531.92View SEC Filing  
2/3/2017Philipp LangDirectorSell108,705$8.60$934,863.00View SEC Filing  
1/25/2017Philipp LangDirectorSell108,985$8.60$937,271.00View SEC Filing  
1/23/2017Philipp LangDirectorSell9,681$8.60$83,256.60View SEC Filing  
1/13/2017Philipp LangDirectorSell37,275$8.60$320,565.00View SEC Filing  
1/11/2017Philipp LangDirectorSell2,800$8.62$24,136.00View SEC Filing  
1/10/2017Philipp LangDirectorSell83,909$8.64$724,973.76View SEC Filing  
1/9/2017Philipp LangDirectorSell6,200$8.65$53,630.00View SEC Filing  
1/5/2017Philipp LangDirectorSell400$8.60$3,440.00View SEC Filing  
1/3/2017Philipp LangDirectorSell74,876$8.00$599,008.00View SEC Filing  
12/30/2016Philipp LangDirectorSell168,734$8.25$1,392,055.50View SEC Filing  
12/28/2016Philipp LangDirectorSell58,547$8.26$483,598.22View SEC Filing  
12/27/2016Philipp LangDirectorSell42,086$8.57$360,677.02View SEC Filing  
12/23/2016Philipp LangDirectorSell30,647$8.62$264,177.14View SEC Filing  
10/17/2016Daniel SteinesInsiderSell889$8.64$7,680.96View SEC Filing  
10/17/2016Paul S WeinerCFOSell884$8.60$7,602.40View SEC Filing  
10/12/2016Daniel SteinesInsiderSell10,000$9.66$96,600.00View SEC Filing  
10/5/2016Philipp LangCEOSell53,860$10.19$548,833.40View SEC Filing  
10/4/2016Philipp LangCEOSell400$10.00$4,000.00View SEC Filing  
10/3/2016Daniel SteinesCTOSell10,000$10.03$100,300.00View SEC Filing  
10/3/2016Philipp LangCEOSell10,410$10.03$104,412.30View SEC Filing  
9/16/2016Daniel SteinesInsiderSell30,000$9.09$272,700.00View SEC Filing  
8/17/2016Kenneth P Fallon IIIDirectorSell4,000$8.44$33,760.00View SEC Filing  
5/17/2016Robert Law IIISVPBuy1,600$6.20$9,920.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for ConforMIS (NASDAQ:CFMS)
Latest Headlines for ConforMIS (NASDAQ:CFMS)
DateHeadline logoHead to Head Comparison: Endologix (ELGX) & ConforMIS (CFMS) - August 13 at 12:40 PM logoConforMIS Inc (CFMS) Reports Acquisition of Machine & Polishing Assets from Broad Peak Manufacturing for $6.5M - August 10 at 6:19 PM logoBrokers Set Expectations for ConforMIS, Inc.'s Q3 2017 Earnings (NASDAQ:CFMS) - August 10 at 12:04 PM logoConforMIS Inc (CFMS) Reports Acquisition of Machine & Polishing ... - - August 9 at 5:18 PM logoConforMIS Acquires Machining and Polishing Assets from Broad Peak Manufacturing - August 9 at 5:18 PM logoUroplasty (UPI) & ConforMIS (CFMS) Critical Review - August 9 at 12:24 PM logoConforMIS, Inc. (NASDAQ:CFMS) Rating Reiterated by Deutsche Bank AG - August 6 at 9:06 PM logoOppenheimer Holdings, Inc. Reiterates $6.00 Price Target for ConforMIS, Inc. (NASDAQ:CFMS) - August 6 at 7:08 PM logoConforMIS, Inc. (NASDAQ:CFMS) Price Target Lowered to $6.00 at Canaccord Genuity - August 6 at 3:18 PM logoConforMIS (CFMS) vs. Second Sight Medical Products (EYES) Head to Head Review - August 6 at 8:06 AM logoConforMIS, Inc. (NASDAQ:CFMS) Expected to Announce Quarterly Sales of $19.76 Million - August 5 at 7:09 AM logoPre-Open Movers 08/04: (YELP) (GPRO) (ANET) Higher; (EFII) (AAOI) (PI) Lower (more...) - August 4 at 10:24 PM logoConforMIS, Inc. (CFMS) Announces Quarterly Earnings Results, Beats Estimates By $0.08 EPS - August 4 at 7:30 PM logoAfter-Hours Stock Movers 08/03: (YELP) (WTW) (ANET) Higher; (AAOI) (PI) (SYNA) Lower (more...) - August 4 at 5:23 PM logoEdited Transcript of CFMS earnings conference call or presentation 3-Aug-17 8:30pm GMT - August 4 at 4:45 AM logoConforMIS reports 2Q loss - August 3 at 11:40 PM logoConforMIS Reports Second Quarter 2017 Financial Results and Updates Fiscal Year 2017 Guidance - August 3 at 6:37 PM logoETFs with exposure to ConforMIS, Inc. : August 1, 2017 - August 1 at 5:52 PM logoWill ConforMIS (CFMS) Continue to Surge Higher? - Nasdaq - July 28 at 6:44 PM logoWill ConforMIS (CFMS) Continue to Surge Higher? - July 28 at 6:44 PM logoConforMIS, Inc. (NASDAQ:CFMS) Receives Average Rating of "Buy" from Brokerages - July 28 at 8:28 AM logoNotable Wednesday Option Activity: NOW, CFMS, LRCX - Nasdaq - July 26 at 5:41 PM logoConforMIS (CFMS) Worth a Look: Stock Jumps 13.4% in Session - July 26 at 5:40 PM logoConforMIS to Host Second Quarter 2017 Financial Results Conference Call and Webcast on August 3, 2017 - GlobeNewswire (press release) - July 20 at 4:21 AM logoConforMIS to Host Second Quarter 2017 Financial Results Conference Call and Webcast on August 3, 2017 - July 19 at 6:17 PM logoComparing Uroplasty (UPI) & ConforMIS (NASDAQ:CFMS) - July 19 at 9:34 AM logoSt Jude Medical (STJ) versus ConforMIS (CFMS) Head-To-Head Survey - July 19 at 8:51 AM logoBTIG Research Reiterates "Hold" Rating for ConforMIS, Inc. (CFMS) - July 18 at 12:56 AM logoFinancial Comparison: ConforMIS (CFMS) and St Jude Medical (STJ) - July 17 at 2:31 PM logo$19.40 Million in Sales Expected for ConforMIS, Inc. (NASDAQ:CFMS) This Quarter - July 14 at 4:24 PM logoConforMIS, Inc. (CFMS) Rating Increased to Buy at Zacks Investment Research - July 12 at 7:10 PM logoConforMIS Names Dan Krupp Senior Vice President US Sales - GlobeNewswire (press release) - July 12 at 5:42 PM logo Brokerages Expect ConforMIS, Inc. (NASDAQ:CFMS) Will Post Earnings of -$0.36 Per Share - July 12 at 8:30 AM logoZacks Investment Research Lowers ConforMIS, Inc. (CFMS) to Sell - July 11 at 10:52 PM logoETFs with exposure to ConforMIS, Inc. : July 11, 2017 - July 11 at 6:08 PM logoConforMIS Names Dan Krupp Senior Vice President U.S. Sales - July 11 at 6:08 PM logoConforMIS, Inc. (CFMS) Given Consensus Rating of "Hold" by Brokerages - July 3 at 10:59 AM logoETFs with exposure to ConforMIS, Inc. : June 26, 2017 - June 26 at 4:56 PM logoRTI Surgical (RTIX) vs. ConforMIS (CFMS) Head to Head Contrast - June 25 at 12:17 PM logoConforMIS, Inc. (CFMS) Director Sells $28,904.60 in Stock - June 22 at 8:16 PM logoConforMIS, Inc. (CFMS) Given "Buy" Rating at Oppenheimer Holdings, Inc. - June 21 at 11:22 PM logoConforMIS Inc (CFMS) Receives FDA 510(k) Clearance for iTotal Hip System - - June 20 at 9:55 PM logoConforMIS, Inc. (CFMS) Research Coverage Started at BTIG Research - June 20 at 5:30 PM logoConforMIS Inc (CFMS) Receives FDA 510(k) Clearance for iTotal Hip System - June 20 at 4:53 PM logoConforMIS Announces FDA 510(k) Clearance for iTotal Hip System - June 20 at 4:53 PM logo$19.40 Million in Sales Expected for ConforMIS, Inc. (CFMS) This Quarter - June 18 at 10:00 AM logoConforMIS (CFMS) versus HeartWare International (HTWR) Financial Analysis - June 16 at 10:48 PM logoETFs with exposure to ConforMIS, Inc. : June 16, 2017 - June 16 at 5:00 PM logo Analysts Anticipate ConforMIS, Inc. (CFMS) to Post -$0.36 EPS - June 16 at 8:46 AM logoConforMIS, Inc. :CFMS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017 - June 14 at 4:59 PM



ConforMIS (CFMS) Chart for Wednesday, August, 16, 2017

This page was last updated on 8/16/2017 by Staff